A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...
A study led by the Department of Medicine, School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong ...
After nonfatal myocardial infarction or stroke, initiation of a GLP-1 receptor agonist was linked to reduced risk for all-cause and CV-related mortality in patients with diabetes, researchers reported ...
“High-sensitivity CRP has been shown to be an independent marker of risk in addition to and in some cases over and above all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results